| Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus GP Fadini, M Miorin, M Facco, S Bonamico, I Baesso, F Grego, ... Journal of the American College of Cardiology 45 (9), 1449-1457, 2005 | 944 | 2005 |
| Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use GP Fadini, D Losordo, S Dimmeler Circulation research 110 (4), 624-637, 2012 | 781 | 2012 |
| Prevalence and impact of diabetes among people infected with SARS-CoV-2 GP Fadini, ML Morieri, E Longato, A Avogaro Journal of endocrinological investigation 43, 867-869, 2020 | 671 | 2020 |
| Endothelial dysfunction in diabetes: the role of reparatory mechanisms A Avogaro, M Albiero, L Menegazzo, S de Kreutzenberg, GP Fadini Diabetes care 34 (Suppl 2), S285, 2011 | 604 | 2011 |
| Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy GP Fadini, S Sartore, M Albiero, I Baesso, E Murphy, M Menegolo, ... Arteriosclerosis, thrombosis, and vascular biology 26 (9), 2140-2146, 2006 | 567 | 2006 |
| Age-associated loss of OPA1 in muscle impacts muscle mass, metabolic homeostasis, systemic inflammation, and epithelial senescence C Tezze, V Romanello, MA Desbats, GP Fadini, M Albiero, G Favaro, ... Cell metabolism 25 (6), 1374-1389. e6, 2017 | 543 | 2017 |
| The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived … GP Fadini, E Boscaro, M Albiero, L Menegazzo, V Frison, ... Diabetes care 33 (7), 1607-1609, 2010 | 410 | 2010 |
| Autologous stem cell therapy for peripheral arterial disease: meta-analysis and systematic review of the literature GP Fadini, C Agostini, A Avogaro Atherosclerosis 209 (1), 10-17, 2010 | 365 | 2010 |
| Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanisms SV de Kreutzenberg, G Ceolotto, I Papparella, A Bortoluzzi, A Semplicini, ... Diabetes 59 (4), 1006-1015, 2010 | 360 | 2010 |
| Sarcoidosis is a Th1/Th17 multisystem disorder M Facco, A Cabrelle, A Teramo, V Olivieri, M Gnoato, S Teolato, E Ave, ... Thorax 66 (2), 144-150, 2011 | 345 | 2011 |
| Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau GP Fadini, I Baesso, M Albiero, S Sartore, C Agostini, A Avogaro Atherosclerosis 197 (2), 496-503, 2008 | 344 | 2008 |
| Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia–reperfusion injury in rats GP Fadini, S Sartore, M Schiavon, M Albiero, I Baesso, A Cabrelle, ... Diabetologia 49, 3075-3084, 2006 | 342 | 2006 |
| NETosis delays diabetic wound healing in mice and humans GP Fadini, L Menegazzo, M Rigato, V Scattolini, N Poncina, A Bruttocao, ... Diabetes 65 (4), 1061-1071, 2016 | 324 | 2016 |
| Convenience versus biological significance: are PMA-differentiated THP-1 cells a reliable substitute for blood-derived macrophages when studying in vitro polarization? S Tedesco, F De Majo, J Kim, A Trenti, L Trevisi, GP Fadini, C Bolego, ... Frontiers in pharmacology 9, 71, 2018 | 321 | 2018 |
| Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk GP Fadini, SV de Kreutzenberg, A Coracina, I Baesso, C Agostini, ... European Heart Journal 27 (18), 2247-2255, 2006 | 318 | 2006 |
| Peripheral Blood CD34+KDR+ Endothelial Progenitor Cells Are Determinants of Subclinical Atherosclerosis in a Middle-Aged General Population GP Fadini, A Coracina, I Baesso, C Agostini, A Tiengo, A Avogaro, ... Stroke 37 (9), 2277-2282, 2006 | 300 | 2006 |
| Cardiovascular effects of DPP-4 inhibition: beyond GLP-1 GP Fadini, A Avogaro Vascular pharmacology 55 (1-3), 10-16, 2011 | 283 | 2011 |
| Rosiglitazone reduces glucose-induced oxidative stress mediated by NAD (P) H oxidase via AMPK-dependent mechanism G Ceolotto, A Gallo, I Papparella, L Franco, E Murphy, E Iori, E Pagnin, ... Arteriosclerosis, thrombosis, and vascular biology 27 (12), 2627-2633, 2007 | 281 | 2007 |
| Endothelial progenitor cells in the natural history of atherosclerosis GP Fadini, C Agostini, S Sartore, A Avogaro Atherosclerosis 194 (1), 46-54, 2007 | 280 | 2007 |
| SGLT2 inhibitors and diabetic ketoacidosis: data from the FDA Adverse Event Reporting System GP Fadini, BM Bonora, A Avogaro Diabetologia 60, 1385-1389, 2017 | 272 | 2017 |